GLEN ALLEN, VA--(Marketwire - February 01, 2012) -
| Highlighted Links |
|
|
Rock Creek Pharmaceuticals, Inc., a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), today announced a new partnership with GNC, the global health and wellness retailer that specializes in premium, value-added nutritional products. Beginning today, customers will be able to purchase Anatabloc™ through GNC’s Internet storefront: http://www.gnc.com. Anatabloc™ assists the body’s natural process for regulating inflammation using an alkaloid found in plants and vegetables, in combination with Vitamins A and D3, to help maintain healthy levels of inflammation. Anatabloc™ was introduced in August 2011 through a dedicated product website.
Rock Creek believes that GNC’s continually expanding Internet presence, together with Anatabloc’s™ online sales model, will create a unique opportunity for both companies. David Dean, Vice President of Sales and Marketing for Star Scientific, stated, “The GNC partnership aligns our business model and pricing structure so that it is consistent with customer feedback on retail price. It also maximizes opportunities for success with the current GNC platform, and the potential for broadening our companies’ relationship. We believe this partnership will be a game-changer for us.”
GNC Gold Card members, under the new partnership with Rock Creek, will be able to purchase Anatabloc™ for $79.99 during the first seven days of every month. Anatabloc™ Advantage Club members also will receive Anatabloc™ automatically shipped at a cost of $79.99. Rock Creek CEO, Paul L. Perito, commented, “The large volume of testimonials we have received since August, which describe real changes in customers’ lifestyle quality, leads us to believe that Anatabloc™ will be a valuable addition to the GNC product line. We look forward to a successful partnership for both companies.” A selection of videotaped testimonials from individuals who have been using Anatabloc, including former #5-ranked tennis professional Jimmy Arias, can be viewed at http://anatabloc.com/anatabloc-athletes/
Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “projects” and similar expressions. The statements in this release are based upon the current beliefs and expectations of the our company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, including with respect to our nutraceuticals, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended December 31, 2010. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.
About Star Scientific
Star Scientific is a technology-oriented company with a mission to reduce the harm associated with tobacco at every level. It is engaged in the development of dissolvable smokeless tobacco products that deliver fewer carcinogenic toxins, principally through the utilization of the innovative StarCured® tobacco curing technology. Its subsidiary, Rock Creek Pharmaceuticals, Inc., is involved in the development of nutraceuticals as well as products to address neurological and mood disorders. Rock Creek Pharmaceuticals has scientific and research offices in Gloucester, MA, and a regulatory office in Washington, D.C. Star Scientific has a Corporate and Sales Office in Glen Allen, VA, an Executive, Scientific & Regulatory Affairs office in Bethesda, MD, and a manufacturing facility in Chase City, VA.
Contact:
Sara Troy Machir
Vice President, Communications & Investor Relations
Email Contact
(301) 654-8300
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
